Clinical Trials Directory

Trials / Completed

CompletedNCT01150019

Correlation Between Circulating Resistin and Vascular Inflammation Measured by 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) (18FDG-PET)

Correlation Between Circulating Resistin and Vascular Inflammation Measured by 18FDG-PET in Obese Person

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Korea University · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Accepted

Summary

Vascular inflammation is a key factor in both the pathogenesis and outcome of atherosclerosis.Resistin was shown to induce vascular endothelial dysfunction and vascular smooth muscle cell proliferation. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a promising tool for identifying and quantifying vascular inflammation within atherosclerotic plaques.Therefore, the purpose of the study is to demonstrate the correlation between circulating resistin and vascular inflammation detected by 18FDG-PET in obese persons.

Conditions

Interventions

TypeNameDescription
OTHERCross sectional studyThis is not intervention study. The purpose of the study is to examine the relationship between various adipokine levels and PET imaging at the cross section setting

Timeline

Start date
2010-04-01
Primary completion
2010-06-01
Completion
2010-06-01
First posted
2010-06-24
Last updated
2010-07-08

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01150019. Inclusion in this directory is not an endorsement.

Correlation Between Circulating Resistin and Vascular Inflammation Measured by 18F-fluorodeoxyglucose (FDG) Positron Emi (NCT01150019) · Clinical Trials Directory